These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death. Passacantilli I; Panzeri V; Terracciano F; Delle Fave G; Sette C; Capurso G Oncol Rep; 2018 Apr; 39(4):1984-1990. PubMed ID: 29393478 [TBL] [Abstract][Full Text] [Related]
63. Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer. Asuthkar S; Stepanova V; Lebedeva T; Holterman AL; Estes N; Cines DB; Rao JS; Gondi CS Mol Biol Cell; 2013 Sep; 24(17):2620-32. PubMed ID: 23864708 [TBL] [Abstract][Full Text] [Related]
64. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
65. BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine. Miller AL; Fehling SC; Vance RB; Chen D; Brown EJ; Hossain MI; Heard EO; Andrabi SA; Wang H; Yang ES; Buchsbaum DJ; van Waardenburg RCAM; Bellis SL; Yoon KJ Cancer Lett; 2024 Jun; 592():216919. PubMed ID: 38704133 [TBL] [Abstract][Full Text] [Related]
66. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation. Ju HQ; Li H; Tian T; Lu YX; Bai L; Chen LZ; Sheng H; Mo HY; Zeng JB; Deng W; Chiao PJ; Xu RH J Pineal Res; 2016 Jan; 60(1):27-38. PubMed ID: 26445000 [TBL] [Abstract][Full Text] [Related]
67. BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism. Sun H; Li H; Guan Y; Yuan Y; Xu C; Fu D; Xie P; Li J; Zhao T; Wang X; Feng Y; Wang H; Gao S; Yang S; Shi Y; Liu J; Chang A; Huang C; Hao J Sci Adv; 2024 Jun; 10(25):eadj8650. PubMed ID: 38896624 [TBL] [Abstract][Full Text] [Related]
68. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207 [TBL] [Abstract][Full Text] [Related]
69. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Dangi-Garimella S; Krantz SB; Barron MR; Shields MA; Heiferman MJ; Grippo PJ; Bentrem DJ; Munshi HG Cancer Res; 2011 Feb; 71(3):1019-28. PubMed ID: 21148071 [TBL] [Abstract][Full Text] [Related]
70. DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine. Liu F; Gore AJ; Wilson JL; Korc M PLoS One; 2014; 9(1):e84982. PubMed ID: 24409315 [TBL] [Abstract][Full Text] [Related]
71. Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma. Wu L; Ge Y; Yuan Y; Li H; Sun H; Xu C; Wang Y; Zhao T; Wang X; Liu J; Gao S; Chang A; Hao J; Huang C Cancer Lett; 2022 Nov; 548():215864. PubMed ID: 35981571 [TBL] [Abstract][Full Text] [Related]
72. Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites. Patzak MS; Kari V; Patil S; Hamdan FH; Goetze RG; Brunner M; Gaedcke J; Kitz J; Jodrell DI; Richards FM; Pilarsky C; Gruetzmann R; Rümmele P; Knösel T; Hessmann E; Ellenrieder V; Johnsen SA; Neesse A EBioMedicine; 2019 Feb; 40():394-405. PubMed ID: 30709769 [TBL] [Abstract][Full Text] [Related]
73. The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma. Park JK; Kim Y; Kim H; Jeon J; Kim TW; Park JH; Hwnag YI; Lee WJ; Kang JS Oncotarget; 2016 Nov; 7(46):75081-75093. PubMed ID: 27655706 [TBL] [Abstract][Full Text] [Related]